Tokyo, Mar 30, 2006 (JCN) - Ono Pharmaceutical and Medarex have signed a collaborative agreement to research and develop a fully human anti-SDF-1 antibody. Under this collaboration, the two companies aim to commercialize a fully human antibody. They will share the costs and responsibilities of research and product development up to the completion of a phase II clinical study.
